| Autor: |
Fazia A. Mir, Alhareth Al Juboori, Jack D. Bragg, Veysel Tahan |
| Jazyk: |
angličtina |
| Rok vydání: |
2018 |
| Předmět: |
|
| Zdroj: |
İstanbul Kuzey Klinikleri, Vol 5, Iss 1, Pp 64-66 (2018) |
| Druh dokumentu: |
article |
| ISSN: |
2148-4902 |
| DOI: |
10.14744/nci.2017.77045 |
| Popis: |
Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematological malignancies, and pancytopenia. Autoimmune hemolytic anemia has rarely been reported in ulcerative colitis. Herein we report a case of drug-induced hemolytic anemia after infliximab infusion for treating ulcerative colitis. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
